Home
Conditions
Diphtheria

Clinical trial condition

Diphtheria

Explore clinical trials studying Diphtheria. Study availability and eligibility vary by location and protocol.

202 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Diphtheria trial results

Completed

Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years

NCT00346073

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +12 more
Locations: GSK Investigational Site Huntsville, Alabama, United States

GSK Investigational Site Chandler, Arizona, United States

GSK Investigational Site Mesa, Arizona, United States

GSK Investigational Site Mesa, Arizona, United States

View all 42 locations

View Trial Details

Completed

Safety of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Healthy Vietnamese Children

NCT01988857

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
Locations: GSK Investigational Site Hanoi, Vietnam

View Trial Details

Completed

Immunogenicity and Safety of a Tetanus-diphtheria Vaccine and a 13-valent Pneumococcal Conjugate Vaccine

NCT03552445

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +8 more
Locations: Not specified

View Trial Details

Completed

Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children

NCT00611559

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +28 more
Locations: GSK Investigational Site Murmansk, Russia

GSK Investigational Site Perm, Russia

GSK Investigational Site Syktyvkar, Russia

View Trial Details

Completed

Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ Vaccine

NCT01086423

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +23 more
Locations: GSK Investigational Site Wuzhou, Guangxi, China

GSK Investigational Site Wuzhou, Guangxi, China

View Trial Details

Completed

Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants

NCT00169442

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +21 more
Locations: GSK Investigational Site City of Muntinlupa, Philippines

GSK Investigational Site Pasay, Philippines

GSK Investigational Site Quezon City, Philippines

View Trial Details

Completed

Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio's DTPa-HBV-IPV/Hib Vaccine

NCT00627458

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
Locations: GSK Investigational Site Jarvenpaa, Finland

GSK Investigational Site Oulu, Finland

GSK Investigational Site Pori, Finland

GSK Investigational Site Tampere, Finland

View Trial Details

Completed

Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib.

NCT00412854

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
Locations: GSK Investigational Site Mengshan, China

GSK Investigational Site Wuzhou, China

View Trial Details

Completed

Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine

NCT00635128

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +24 more
Locations: GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany

GSK Investigational Site Kehl, Baden-Wurttemberg, Germany

GSK Investigational Site Oberkirch, Baden-Wurttemberg, Germany

GSK Investigational Site Offenburg, Baden-Wurttemberg, Germany

View all 38 locations

View Trial Details

Completed

Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine

NCT01449812

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +11 more
Locations: GSK Investigational Site Wuzhou, Guangxi, China

GSK Investigational Site Wuzhou, Guangxi, China

View Trial Details

Diphtheria

Diphtheria trial results

Related conditions